Global Stem Cell Umbilical Cord Blood Market 2015-2019

Aug 31, 2015, 12:04 ET from ReportBuyer

LONDON, Aug. 31, 2015 /PRNewswire/ -- About Stem Cell UCB
UCB is the blood that remains in the placenta and the attached umbilical cord after childbirth. UCB contains stem cells that are unique, smart, and are capable of treating several life-threatening diseases. They are used in the treatment of hematopoietic and genetic disorders. The placental blood can produce 10 times more quantity of stem cells compared to the umbilical cord, which can in turn be used for the treatment of an adult patient. The cord blood that is collected during the childbirth is stored and cryopreserved. The storage of the cord blood can be done at private cord blood banks or public cord blood banks. This preserved blood can be used for the transplantation, and treatment of diseases at the later stages of life.

Technavio's analysts forecast the global stem cell UCB market to grow at a CAGR of 30.36% over the period 2014-2019.

Covered in this Report
The report covers the present scenario and the growth prospects of the global stem cell UCB market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the banking and utilization of UCB stem cells for the treatment of various disorders, such as cancers, blood disorders, metabolic disorders, immune diseases, and others.

Technavio's report, Global Stem Cell UCB Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global stem cell UCB market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
- Americas
- APAC
- EMEA

Key Vendors
- Caladrius Biosciences
- Celgene
- Mesoblast
- Pluristem Therapeutics

Other Prominent Vendors
- Athersys
- CHA Bio & Diostech
- Cytori Therapeutics
- Nuo Therapeutics
- Ocata Therapeutics
- Opexa Therapeutics
- Osiris Therapeutics
- Teva Pharmaceuticals
- United Therapeutics

Key Market Driver
- Effective Treatment of Life-threatening Diseases
- For a full, detailed list, view our report

Key Market Challenge
- Stringent Regulations
- For a full, detailed list, view our report

Key Market Trend
- Growing Public Awareness
- For a full, detailed list, view our report

Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Download the full report: https://www.reportbuyer.com/product/3200296/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer



RELATED LINKS

http://www.reportbuyer.com